- Home
- MLYS vs DOCN Comparison
MLYS vs DOCN Comparison
Compare MLYS & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- DOCN
- Stock Information
- Founded
- MLYS 2019
- DOCN 2011
- Country
- MLYS United States
- DOCN United States
- Employees
- MLYS N/A
- DOCN N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- DOCN Retail: Computer Software & Peripheral Equipment
- Sector
- MLYS Health Care
- DOCN Technology
- Exchange
- MLYS Nasdaq
- DOCN Nasdaq
- Market Cap
- MLYS 3.1B
- DOCN 3.0B
- IPO Year
- MLYS 2023
- DOCN 2021
- Fundamental
- Price
- MLYS $38.06
- DOCN $37.38
- Analyst Decision
- MLYS Strong Buy
- DOCN Buy
- Analyst Count
- MLYS 6
- DOCN 13
- Target Price
- MLYS $42.60
- DOCN $41.92
- AVG Volume (30 Days)
- MLYS 1.6M
- DOCN 2.7M
- Earning Date
- MLYS 11-10-2025
- DOCN 11-03-2025
- Dividend Yield
- MLYS N/A
- DOCN N/A
- EPS Growth
- MLYS N/A
- DOCN 87.43
- EPS
- MLYS N/A
- DOCN 1.32
- Revenue
- MLYS N/A
- DOCN $832,812,000.00
- Revenue This Year
- MLYS N/A
- DOCN $16.34
- Revenue Next Year
- MLYS N/A
- DOCN $14.52
- P/E Ratio
- MLYS N/A
- DOCN $28.41
- Revenue Growth
- MLYS N/A
- DOCN 13.29
- 52 Week Low
- MLYS $8.24
- DOCN $25.45
- 52 Week High
- MLYS $41.09
- DOCN $47.02
- Technical
- Relative Strength Index (RSI)
- MLYS 62.11
- DOCN 58.53
- Support Level
- MLYS $37.32
- DOCN $33.69
- Resistance Level
- MLYS $40.51
- DOCN $35.78
- Average True Range (ATR)
- MLYS 2.09
- DOCN 1.53
- MACD
- MLYS -0.77
- DOCN -0.05
- Stochastic Oscillator
- MLYS 43.86
- DOCN 66.38
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.